APPENDIX J 
For example, research agencies on the Committee are working in coordination 
with the National Institutes of Health and its Recombinant DNA Molecule 
Program Advisory Committee on setting standards and certifying new host-vector 
systems. The research agencies have also been developing a registry of 
projects supported by Federal funds. The survey being taken in the private 
sector by the Pharmaceutical Manufacturers Association and the Industrial 
Research Institute will provide data on the industry, in anticipation of 
registration under a new law. 
The Committee will consider suggestions by the representatives from 
the State Department concerning further means to ensure international 
control in the use and production of recombinant DNA molecules. At 
present, there is voluntary coordination and cooperation among national 
scientific bodies. The Biological Weapons Convention is considered by 
the State Department to prohibit development, production, or stockpiling 
of recombinant DNA molecules for purposes of biological warfare. The 
Committee will review whether other measures need to be considered for 
international control. 
The Committee will also be reviewing current Federal policies on 
the matter of patenting recombinant DNA inventions and other matters of 
concern that may need to be addressed before the Committee concludes its 
business and files a final report. 
Appendix J — 22 
